药理实验表明，此类化合物或其药学上可接受的盐对各种肿瘤细胞的增殖具有抑制作用。
Pharmacological experiment proves that the compound or relative medical acceptable salt can restrain various cancer cell proliferations.
方法： 行病毒增殖实验和细胞生长抑制实验，验证CNHK500选择性复制和杀伤能力；
Methods: We used virus proliferation assay cell viability assay to evaluate the proliferation and cytolysis selectivity of CNHK500.
研究表明灵菌红素抑制细胞的增殖，与抑制S期细胞的DNA复制及调控细胞的增殖周期相关。 同时，细胞凋亡的产生与实验药物呈正相关。
The inhibitive effect of prodigiosin on multiplication of cancer cells was related to the inhibiting of DNA replication in S stage and regulating of cell cycle.
体外刺激脾淋巴细胞增殖实验以及体外肿瘤细胞增殖抑制试验表明该蛋白具备良好的超抗原活性。
The typical superantigen activity of the purified protein was proved by lymphocyte proliferation test and tumor growth inhibition test.
体外实验表明，VEGI能显著抑制牛动脉内皮细胞与人脐静脉内皮细胞的增殖；
VEGI can markedly inhibit the growth of endothelial cells but not that of other types of cells examined.
经实验证实，该类化合物可作为细胞增殖抑制剂、细胞凋亡诱导剂或抗肿瘤剂。
Experiments prove that the compounds can be used as a cell proliferation inhibitor, an apoptosis inducer or an antitumor agent.
经实验证实，该类化合物可作为细胞增殖抑制剂、细胞凋亡诱导剂或抗肿瘤剂。
Tests prove that the compounds can be used as a cell proliferation inhibitor, an apoptosis inducer or an anti-tumor agent.
经实验证实，该类化合物可作为细胞增殖抑制剂或抗肿瘤剂。
Tests prove that: the compounds can be used as cellular breeding depressant or anti-tumor agent.
体外刺激脾淋巴细胞增殖实验以及体外肿瘤细胞增殖抑制试验表明该蛋白具备良好的超抗原活性。
The total yield was 23% with the purity of 90%. The typical superantigen activity of the purified protein was proved by lymphocyte proliferation test and tumor growth inhibition test.
体外刺激脾淋巴细胞增殖实验以及体外肿瘤细胞增殖抑制试验表明该蛋白具备良好的超抗原活性。
The total yield was 23% with the purity of 90%. The typical superantigen activity of the purified protein was proved by lymphocyte proliferation test and tumor growth inhibition test.
应用推荐